Page last updated: 2024-09-05

sorafenib and fuberidazole

sorafenib has been researched along with fuberidazole in 1 studies

Compound Research Comparison

Studies (sorafenib)	Trials (sorafenib)	Recent Studies (post-2010) (sorafenib)	Studies (fuberidazole)	Trials (fuberidazole)	Recent Studies (post-2010) (fuberidazole)
6,520	730	5,251	19	0	9

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abdel-Mohsen, HT; Abdullaziz, MA; Abu-Bakr, SM; Ali, MM; El Diwani, HI; El Kerdawy, AM; Girgis, AS; Ragab, FAF	1

Other Studies

1 other study(ies) available for sorafenib and fuberidazole

Article	Year
Design, synthesis, molecular docking and cytotoxic evaluation of novel 2-furybenzimidazoles as VEGFR-2 inhibitors. European journal of medicinal chemistry, 2017, Aug-18, Volume: 136 Topics: Antineoplastic Agents; Benzimidazoles; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Furans; Hep G2 Cells; Humans; MCF-7 Cells; Molecular Docking Simulation; Molecular Structure; Protein Kinase Inhibitors; Structure-Activity Relationship; Vascular Endothelial Growth Factor Receptor-2	2017

Article

Year

Design, synthesis, molecular docking and cytotoxic evaluation of novel 2-furybenzimidazoles as VEGFR-2 inhibitors.

European journal of medicinal chemistry, 2017, Aug-18, Volume: 136

Topics: Antineoplastic Agents; Benzimidazoles; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Furans; Hep G2 Cells; Humans; MCF-7 Cells; Molecular Docking Simulation; Molecular Structure; Protein Kinase Inhibitors; Structure-Activity Relationship; Vascular Endothelial Growth Factor Receptor-2

2017